Dow Wolff Cellulosics delivers high-performance cellulose derivatives and companion chemistries used for formulations across a broad variety of applications in the Food & Nutrition and Pharmaceutical  markets.  Our goal is to tailor polymer chemistry, morphology, and blending into solutions that enable our customers to provide consumers healthier outcomes.   In our Pharmaceutical group, innovative solutions across both the Immediate and Modified Release segments are in development to address performance, regulatory, and sustainability initiatives from dosage form development through commercialization.  Areas of focus include the development of enhanced structure/functionality-property relationships enabling enhanced Quality-by-Design and the development of materials and processes that can deliver improved product performance and sustainability vs. conventional methods in matrix and osmotic formulations, coatings, capsules, and granulation.  In our Food and Nutrition group, innovative products are in development that benefit consumer health, convenience, and help manufacturers overcome formulation challenges � efforts in Appetite Control and Gluten Replacement will be discussed.

Health by design: How Dow Wolff Cellulosics is enabling drug and nutrition benefit delivery

244th National Meeting (2012)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.